Abstract:Florbetapir PET images were used to compare cerebral amyloid burden in participants with post-traumatic stress disorder (PTSD) and in control subjects without PTSD or history of traumatic brain injury. Since PTSD participants had suggestive evidence of lower (not higher) standard uptake value ratios (SUVRs) than the controls in the frontal cortex, since antidepressants are commonly used in persons with PTSD, and since serotonin-reuptake inhibitors (SSRIs) have been shown to be associated with cerebrospinal fluid and PET evidence of lower amyloid accumulation (Cirrito, 2011; Sheline, 2014), post-hoc analyses were performed to investigate the possibility that these findings are attributable to antidepressant use. Mean cerebral-to-cerebellar SUVRs, an amyloid positive threshold of 1.18 consistent with moderate-to-severe amyloid plaques (Fleisher, 2011), and statistical brain maps (SPM) were used to compare florbetapir PET scans from 52 male participants with PTSD (68±4 years old, 4 with mild cognitive impairment [MCI]) and 52 male controls (71±6 years old, 2 with MCI). Post-hoc analyses were performed to determine whether regional SUVR differences are attributable to antidepressant use in 24 PTSD patients (including 15 on an SSRI) and 3 controls (including 1 on an SSRI). PTSD and control groups did not differ in their mean cerebral SUVRs corrected for age and education (P=0.18; P=0.04 without age/education correction). However, the PTSD group had a significantly lower percentage of amyloid positive participants (PTSD: 3.8%, NC: 19.2%; P=0.01). Brain maps revealed significantly lower regional SUVRs in the PTSD group, primarily in the frontal cortex (P<0.005, corrected for age and education, uncorrected for multiple comparisons). Regional differences were no longer apparent after correction for antidepressant use. Furthermore, antidepressant users were distinguished from non-users by significantly lower frontal SUVRs (uncorrected P<0.005), a significantly lower percentage of amyloid positive subjects (users: 0%, non-users: 15.6%; P=0.03), and a significantly greater proportion of cerebral voxels with lower SUVRs (Monte-Carlo Simulation, P<0.001). While preliminary, our findings suggest that adults with PTSD have less fibrillar amyloid and that this reduction may be at least partly attributable to antidepressant use. They support the possibility that antidepressants are associated with reduced amyloid plaque burden and with a lower risk of AD.

Serotonergic and Noradrenergic Markers of Post-Traumatic Stress Disorder with and Without Major Depression

Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression

Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder

Elevated Serum Interleukin-6 (Il-6) and Il-6 Receptor Concentrations in Posttraumatic Stress Disorder Following Accidental Man-Made Traumatic Events

Proton Magnetic Resonance Spectroscopy in Post-Traumatic Stress Disorder—Updated Systematic Review and Meta-Analysis

Predator Exposure/Psychosocial Stress Animal Model of Post-Traumatic Stress Disorder Modulates Neurotransmitters in the Rat Hippocampus and Prefrontal Cortex

A study of tryptophan, kynurenine and serotonin transporter in first-episode drug-naïve major depressive disorder

Peripheral Markers of Serotonergic and Noradrenergic Function in Post-Pubertal, Caucasian Males with Autistic Disorder

Fatty acid concentrations in patients with posttraumatic stress disorder compared to healthy controls

Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders

Prefrontal metabolite alterations in individuals with posttraumatic stress disorder: a 7T magnetic resonance spectroscopy study

Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders.

Probing the neurocardiac circuit in trauma and posttraumatic stress

Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD

Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder

P656. Psychological Functioning, Neurosteroids, and White Matter Microstructure in the Context of Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury

A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder

Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis

Lower frontal amyloid burden in antidepressant users: preliminary findings from persons with and without post-traumatic stress disorder in the adni dod study

Patterns of Altered Cortical Perfusion and Diminished Subcortical Integrity in Posttraumatic Stress Disorder: an Mri Study